ClinConnect ClinConnect Logo
Search / Trial NCT06453148

Brazilian Clinical Registry of Heart Transplantation

Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Jun 7, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

The Brazilian Clinical Registry of Heart Transplantation is a study designed to understand how patients do after receiving a heart transplant. This research will include up to 730 patients who have had a heart transplant in Brazil, and it will follow them for one year after their surgery. The study aims to track important health information, such as hospital visits and any deaths, to help improve care for heart transplant patients in the future.

To be eligible for this study, patients must be at least 18 years old and have undergone heart transplantation within the last 30 days. Participants will have two follow-up visits, one at six months and another at twelve months after the transplant, where their health will be monitored through tests and assessments. This study is not yet recruiting participants, but it is an important step towards understanding and improving the long-term health of those who have received a heart transplant.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients over 18 years old;
  • Heart Transplantation within 30 days of both sexes;
  • Exclusion Criteria:
  • Refusal to provide consent for the study;
  • In the judgment of the local investigator, any difficulty accessing follow-up visits

About Hospital Israelita Albert Einstein

Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.

Locations

São Paulo, , Brazil

Patients applied

0 patients applied

Trial Officials

Fernando Bacal, PhD

Study Chair

Heart Transplantation Coordinator - Hospital Albert Einstein

Henrique A Fonseca, PhD

Principal Investigator

Head of Vaccines and Immunobiology Clinical Trial - ARO-EINSTEIN

Iascara Wozniak de Campos, PhD

Principal Investigator

Clinical Trialist - ARO - EINSTEIN

Luiz V Rizzo, PhD

Principal Investigator

Director - ARO - EINSTEIN

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported